Clearside Biomedical Cash from Financing (TTM) Insights

Clearside Biomedical Inc (CLSD)

1.32 0.00 (0.00%) USD | NASDAQ | May 03, 16:00

1.32 0.00 (0.00%) After-Hours: 19:29

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	0.414M
September 30, 2023	1.246M
June 30, 2023	31.62M
March 31, 2023	31.60M
December 31, 2022	31.33M
September 30, 2022	30.92M
June 30, 2022	2.315M
March 31, 2022	9.428M
December 31, 2021	23.78M
September 30, 2021	30.50M
June 30, 2021	30.85M
March 31, 2021	21.09M
December 31, 2020	7.867M
September 30, 2020	-0.662M
June 30, 2020	-0.667M
March 31, 2020	3.26M
December 31, 2019	8.695M

Date	Value
September 30, 2019	10.36M
June 30, 2019	7.936M
March 31, 2019	9.389M
December 31, 2018	81.78M
September 30, 2018	81.83M
June 30, 2018	81.83M
March 31, 2018	79.25M
December 31, 2017	5.362M
September 30, 2017	38.77M
June 30, 2017	46.81M
March 31, 2017	91.52M
December 31, 2016	86.39M
September 30, 2016	72.86M
June 30, 2016	64.83M
March 31, 2016	25.94M
December 31, 2015	25.94M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.667M

Minimum

Jun 2020

31.62M

Maximum

Jun 2023

14.84M

Average

9.428M

Median

Mar 2022

Cash from Financing (TTM) Benchmarks